Patents/Assignees

Modernatx, Inc.

95 patents in portfolio

US11911453utility2024
RSV RNA Vaccines
0 cites
US11911474utility2024
Delivery and Formulation of Engineered Nucleic Acids
0 cites
US11912982utility2024
Methods for HPLC Analysis
0 cites
US11905525utility2024
Reduction of Elimination of Immune Responses to Non-intravenous, E.g., Subcutaneously Administered Therapeutic Proteins
0 cites
US11872278utility2024
Combination HMPV/RSV RNA Vaccines
0 cites
US11873327utility2024
Polynucleotides Encoding Tethered Interleukin-12 (IL12) Polypeptides and Uses Thereof
0 cites
US11866475utility2024
Modified RNA Encoding VEGF-A Polypeptides, Formulations, and Uses Relating Thereto
0 cites
US11866696utility2024
Analytical HPLC Methods
0 cites
US11866754utility2024
Trinucleotide Mrna Cap Analogs
0 cites
US11859215utility2024
Polynucleotides Encoding Ornithine Transcarbamylase for the Treatment of Urea Cycle Disorders
0 cites
US11851694utility2023
High Fidelity in Vitro Transcription
0 cites
US11845772utility2023
Ribonucleic Acid Purification
0 cites
US11801227utility2023
Polynucleotides Encoding Cystic Fibrosis Transmembrane Conductance Regulator for the Treatment of Cystic Fibrosis
0 cites
US11786607utility2023
RNA Formulations
0 cites
US11767548utility2023
RNA Polymerase Variants
0 cites
US11752206utility2023
Herpes Simplex Virus Vaccine
0 cites
US11744801utility2023
Methods of Making Lipid Nanoparticles
0 cites
US11708396utility2023
Signal-sensor Polynucleotides for the Alteration of Cellular Phenotypes
0 cites
US11696892utility2023
Lipid Nanoparticles for Delivering Modified RNA Encoding a VEGF-A Polypeptide
0 cites
US11696946utility2023
Influenza Vaccine
0 cites

← PreviousPage 4 of 5Next →